These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10094880)

  • 21. Cytotoxic effects of müllerian inhibiting substance (MIS)?
    Janssens JP; Noto V; van Tendeloo G; Bonte J; de Loecker W
    Anticancer Res; 1988; 8(4):781-4. PubMed ID: 3178166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimüllerian hormone as a serum marker of granulosa cell tumorsof the ovary: comparative study with serum alpha-inhibin and estradiol.
    Rey RA; Lhommé C; Marcillac I; Lahlou N; Duvillard P; Josso N; Bidart JM
    Am J Obstet Gynecol; 1996 Mar; 174(3):958-65. PubMed ID: 8633676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An immunoassay to detect human müllerian inhibiting substance in males and females during normal development.
    Hudson PL; Dougas I; Donahoe PK; Cate RL; Epstein J; Pepinsky RB; MacLaughlin DT
    J Clin Endocrinol Metab; 1990 Jan; 70(1):16-22. PubMed ID: 2294129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum Müllerian-inhibiting substance levels in adolescent girls with normal menstrual cycles or with polycystic ovary syndrome.
    Siow Y; Kives S; Hertweck P; Perlman S; Fallat ME
    Fertil Steril; 2005 Oct; 84(4):938-44. PubMed ID: 16213847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cleavage of Müllerian inhibiting substance activates antiproliferative effects in vivo.
    Kurian MS; de la Cuesta RS; Waneck GL; MacLaughlin DT; Manganaro TF; Donahoe PK
    Clin Cancer Res; 1995 Mar; 1(3):343-9. PubMed ID: 9815990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mullerian inhibiting substance levels at the time of HCG administration in IVF cycles predict both ovarian reserve and embryo morphology.
    Silberstein T; MacLaughlin DT; Shai I; Trimarchi JR; Lambert-Messerlian G; Seifer DB; Keefe DL; Blazar AS
    Hum Reprod; 2006 Jan; 21(1):159-63. PubMed ID: 16123085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recurrent ovarian granulosa cell tumors: clinical and imaging features.
    Rha SE; Oh SN; Jung SE; Lee YJ; Lee AW; Byun JY
    Abdom Imaging; 2008; 33(1):119-25. PubMed ID: 17624570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prospective study of inhibin in granulosa cell tumors of the ovary.
    Jobling T; Mamers P; Healy DL; MacLachlan V; Burger HG; Quinn M; Rome R; Day AJ
    Gynecol Oncol; 1994 Nov; 55(2):285-9. PubMed ID: 7959297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol.
    Hazout A; Bouchard P; Seifer DB; Aussage P; Junca AM; Cohen-Bacrie P
    Fertil Steril; 2004 Nov; 82(5):1323-9. PubMed ID: 15533354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant human Mullerian inhibiting substance inhibits long-term growth of MIS type II receptor-directed transgenic mouse ovarian cancers in vivo.
    Pieretti-Vanmarcke R; Donahoe PK; Szotek P; Manganaro T; Lorenzen MK; Lorenzen J; Connolly DC; Halpern EF; MacLaughlin DT
    Clin Cancer Res; 2006 Mar; 12(5):1593-8. PubMed ID: 16533786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measurements of serum müllerian inhibiting substance in the evaluation of children with nonpalpable gonads.
    Lee MM; Donahoe PK; Silverman BL; Hasegawa T; Hasegawa Y; Gustafson ML; Chang YC; MacLaughlin DT
    N Engl J Med; 1997 May; 336(21):1480-6. PubMed ID: 9154766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measurement of Mullerian inhibiting substance facilitates management of boys with microphallus and cryptorchidism.
    Misra M; MacLaughlin DT; Donahoe PK; Lee MM
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3598-602. PubMed ID: 12161481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant human mullerian inhibiting substance inhibits human ocular melanoma cell lines in vitro and in vivo.
    Parry RL; Chin TW; Epstein J; Hudson PL; Powell DM; Donahoe PK
    Cancer Res; 1992 Mar; 52(5):1182-6. PubMed ID: 1531323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abnormal sexual development in transgenic mice chronically expressing müllerian inhibiting substance.
    Behringer RR; Cate RL; Froelick GJ; Palmiter RD; Brinster RL
    Nature; 1990 May; 345(6271):167-70. PubMed ID: 2336108
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum levels of mullerian inhibiting substance in boys throughout puberty and in the first two years of life.
    Baker ML; Hutson JM
    J Clin Endocrinol Metab; 1993 Jan; 76(1):245-7. PubMed ID: 8421093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Developmental changes in mullerian inhibiting substance in the cynomolgus monkey, Macaca fascicularis.
    Lee MM; Gustafson ML; Ukiyama E; Donahoe PK; MacLaughlin DT; Wexler M; Keeping HS
    J Clin Endocrinol Metab; 1994 Mar; 78(3):615-21. PubMed ID: 8126132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mullerian inhibiting substance inhibits colony growth of a human ovarian carcinoma cell line.
    Fuller AF; Guy S; Budzik GP; Donahoe PK
    J Clin Endocrinol Metab; 1982 May; 54(5):1051-5. PubMed ID: 6895900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of Müllerian inhibiting substance in biological samples by a solid phase sandwich radioimmunoassay.
    Necklaws EC; LaQuaglia MP; MacLaughlin D; Hudson P; Mudgett-Hunter M; Donahoe PK
    Endocrinology; 1986 Feb; 118(2):791-6. PubMed ID: 3753678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibin as a marker for granulosa-cell tumors.
    Lappöhn RE; Burger HG; Bouma J; Bangah M; Krans M; de Bruijn HW
    N Engl J Med; 1989 Sep; 321(12):790-3. PubMed ID: 2770810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autocrine and paracrine Müllerian inhibiting substance hormone signaling in reproduction.
    Ingraham HA; Hirokawa Y; Roberts LM; Mellon SH; McGee E; Nachtigal MW; Visser JA
    Recent Prog Horm Res; 2000; 55():53-67; discussion 67-8. PubMed ID: 11036933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.